MIRA Pharmaceuticals (MIRA) News Today $1.90 -0.29 (-13.24%) (As of 11/1/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Mira Pharmaceuticals announces preclinical data on Ketamir-2October 29, 2024 | markets.businessinsider.comMIRA Pharmaceuticals Shares Surge 40% After Ketamir-2 Excels in Pain Management TrialsOctober 29, 2024 | finance.yahoo.comMIRA Pharmaceuticals' Formulated Shows Greater Efficacy Than FDA-Approved Drug For Chemo-Induced Neuropathic PainOctober 28, 2024 | finance.yahoo.comMIRA says Ketamir-2 outperforms FDA-approved neuropathic pain treatmentsOctober 23, 2024 | markets.businessinsider.comMIRA Continues to Post Outstanding Test ResultsOctober 21, 2024 | msn.comMira Pharmaceuticals (NASDAQ:MIRA) Stock, Short Interest ReportOctober 9, 2024 | benzinga.comSmall Changes… Big Effects! Breakthrough Therapies Are The Name Of The Game For This BiopharmaOctober 3, 2024 | msn.comRodman & Renshaw Initiates Coverage of MIRA Pharmaceuticals (MIRA) with Buy RecommendationOctober 1, 2024 | msn.comWhy Mira Shares Are Trading Higher TodaySeptember 27, 2024 | msn.comMIRA Makes Impressive ProgressSeptember 18, 2024 | msn.comPeering Into Mira Pharmaceuticals's Recent Short InterestSeptember 11, 2024 | benzinga.comBioMedNewsBreaks – Telomir Pharmaceuticals Inc. (NASDAQ: TELO) Appoints Pharmaceutical Innovation Veteran as Chief Scientific AdvisorSeptember 4, 2024 | msn.comMIRA Announces Significant Test ResultsAugust 27, 2024 | msn.comMidday stock movers: Temu Parent, Planet Fitness, MIRA PharmaceuticalsAugust 26, 2024 | msn.comMIRA Pharmaceuticals' Oral Ketamine Analog Achieves Complete Normalization Of Neuropathic Pain In Animal StudiesAugust 26, 2024 | benzinga.comWhy MIRA Pharmaceuticals Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving PremarketAugust 26, 2024 | msn.comStocks to Watch: MIRA Pharmaceuticals, Talis BiomedicalAugust 24, 2024 | marketwatch.comMIRA Pharmaceuticals' Shares Soar on Ketamine-Analog Drug Study ResultsAugust 24, 2024 | marketwatch.comMIRA Reports Promising Pre-Clinical Results For Ketamir-2 In Neuropathic Pain Study; Stock UpAugust 24, 2024 | markets.businessinsider.comMIRA Pharmaceuticals, Inc. (K6S.F)August 18, 2024 | finance.yahoo.comMIRA Continues to Reveal Advances in TreatmentAugust 16, 2024 | msn.comIntelliguard, Cencora Partner to Increase Compatibility of RFID-Tagged Medications, Medication Management SystemsAugust 14, 2024 | finance.yahoo.comTELOMIR PHARMACEUTICALS, INC.: Telomir Pharmaceuticals Mourns the Passing of Chairman and CEO Dr. Christopher ChapmanAugust 13, 2024 | finanznachrichten.deMIRA Mira Pharmaceuticals files $100M mixed securities shelfAugust 13, 2024 | msn.comTelomir Pharmaceuticals Mourns the Passing of Chairman and CEO Dr. Christopher ChapmanAugust 12, 2024 | finance.yahoo.comTelomir Pharmaceuticals Chair, CEO Christopher Chapman Passes AwayAugust 12, 2024 | marketwatch.comMIRA Pharmaceuticals regains Nasdaq complianceAugust 10, 2024 | uk.investing.comAscendiant Capital Initiates Coverage of MIRA Pharmaceuticals (MIRA) with Buy RecommendationAugust 7, 2024 | msn.comMIRA Pharmaceuticals, Inc. (MIRA)August 1, 2024 | finance.yahoo.comDow Rebounds Nearly 500 Points; Warren Buffett Unloads Key HoldingJuly 25, 2024 | msn.comMental Health Disorders-Focused MIRA Pharmaceuticals Unveils Additional Preclinical DataJuly 25, 2024 | benzinga.comPre-market Movers: Psyence Biomedical, 2U, Inc., IF Bancorp, MIRA Pharmaceuticals, Predictive OncologyJuly 25, 2024 | finanznachrichten.deStocks Mixed After GDP Data; Software Firm Breaks Out As Nasdaq Falls FurtherJuly 25, 2024 | msn.comWe're Not Very Worried About MIRA Pharmaceuticals' (NASDAQ:MIRA) Cash Burn RateJuly 24, 2024 | finance.yahoo.comTriastek Announces Research Collaboration and Platform Technology License Agreement with BioNTech to Advance 3D Printed Oral RNA TherapeuticsJuly 24, 2024 | finance.yahoo.comWhy Is Mira Pharmaceuticals (MIRA) Stock Down 27% Today?July 23, 2024 | investorplace.com60 Degrees Pharmaceuticals enters deals for babesiosis treatment trialJuly 22, 2024 | finance.yahoo.comHealth Care Stocks Post Moderate Gains -- Health Care RoundupJuly 22, 2024 | marketwatch.comS&P 500 Gains 1%; MIRA Pharmaceuticals Shares Spike HigherJuly 22, 2024 | benzinga.comS&P 500 Gains 1%; MIRA Pharmaceuticals Shares Spike HigherJuly 22, 2024 | benzinga.comWhy Is MIRA Pharmaceuticals (MIRA) Stock Up 318% Today?July 22, 2024 | investorplace.comMIRA Posts More Positive Test ResultsJuly 22, 2024 | msn.comNano-Cap MIRA Pharmaceuticals' Oral Ketamine Analog Shows Potential In Neuropsychiatric DisordersJuly 22, 2024 | benzinga.comMIRA Pharmaceuticals Shares More Than Quadruple on Favorable DataJuly 22, 2024 | marketwatch.comWhy Is MIRA Pharmaceuticals (MIRA) Stock Up 318% Today?July 22, 2024 | investorplace.comMIRA Announces More Positive Test ResultsJuly 19, 2024 | msn.comMIRA Pharmaceuticals Announces Ketamir-2 Shows Promising Safety Profile in Comparison to Traditional Ketamine In Preclinical TestingJune 24, 2024 | prnewswire.comMira Pharmaceuticals Announces Positive Preclinical Study Results For Its Novel Oral ketamine Analog, Ketamir-2, Paving the Way for IND Submission Later This YearJune 10, 2024 | prnewswire.comMira Pharmaceuticals Announces DEA Rules MIRA-55, a Novel Oral Pharmaceutical Marijuana Analog, Is Not Classified as a Controlled SubstanceMay 29, 2024 | prnewswire.comMIRA Announces Important Collaboration PotentialMay 22, 2024 | finance.yahoo.com Get MIRA Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for MIRA and its competitors with MarketBeat's FREE daily newsletter. Email Address 625,000% Gain (Ad)Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz. >> Dive into the Workshop Here MIRA Media Mentions By Week MIRA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MIRA News Sentiment▼0.380.42▲Average Medical News Sentiment MIRA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MIRA Articles This Week▼32▲MIRA Articles Average Week Get MIRA Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for MIRA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Checkpoint Therapeutics News Today Aclaris Therapeutics News Today Annovis Bio News Today Rani Therapeutics News Today Tiziana Life Sciences News Today Seres Therapeutics News Today PDS Biotechnology News Today 23andMe News Today INmune Bio News Today Werewolf Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MIRA) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…Crypto 101 Media | Sponsored[Just Released] Jovine's Emergency Briefing insidePeople didn't believe Jovine when he predicted the 2008 financial crisis over a year in advance. But some read...Behind the Markets | SponsoredHe made 1,303,329 in 12 months after Biden won…Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MIRA Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MIRA Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
